An enzyme-linked im munosorbent assay (ELISA) for rat a2-macroglobulin (a2M ) using a monoclonal antibody was developed, and used to measure a2M in sera from rats injected intramuscularly with turpentine oil as an in¯am matory agent. T he mean concentration of a2M gradually increased and peaked 2 days after the turpentine oil injection. T he peak a2M concentration ranged from 2362±8472 mg/ml (mean 4531 mg/ml), which was 50±290 times higher than the pre-dosing levels of 23±61 mg/ml. In addition, interleukins (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, and interferon (IFN )-g were measured using commercial ELISA reagent kits. IL-6 and IL-8 increased and peaked 12 h after turpentine oil injection, the levels being 5±51 times and 2±38 times the pre-dosing ones, respectively. T he concentrations of IL-1, IL-2, IL-4, IL-10 and IFN-g in rat s injected with turpentine oil did not change.
antibody; rat; serum In 1955, the presence of rat a2-m acroglobulin (a2M ) in sera from tum our-bearing rat s, but not in sera from normal rat s, was described by Darcy (1955 ) . a2M has also been found in sera from foetal, neonatal and pregnant rats (Darcy 1957 ) . Serum levels of a2M are low in normal rats and increase in injured or turpentine oil-injected rats (Gordon 1976 , Okubo e t a l. 1981 . It is recognized that rat a2M is one of the acute phase proteins.
Rat serum a2M concentrations have been measured by electroimmunoassay (Ganrot 1973 , Okubo e t a l. 1981 ), single radial immunodiffusi on (Gordon 1976 ) and ELISA (Ikawa & Shozen 1990 , Kim & Park 1997 Inoue e t a l. 2002 ) . All of these methods used polyclonal antibodies. T his paper describes the development of an ELISA using a mono-clonal antibody (m Ab) for rat a2M, and the use of this assay to measure serum a2M in rats injected with turpentine oil.
It has been suggested that the interleukins IL-1, IL-6 and tum our necrosis factor are inducers of a2M production in rats (Bauer e t a l. 1985, Andus e t a l. 1988 ). IL-1, IL-6 and IL-8 have also been called in¯ammatory cytok ines, and these cytok ines increase following tissue dam age (Ikei e t a l. 1992, Matsushita e t a l. 1998 ). T he interleukins IL-1, IL-2, IL-4, IL-6, IL-8, IL-10 and IFN-g were also measured in this study.
Materials and methods

Anim a ls
All rats were individual ly housed in cages (280(w)6440(D )6180(H) mm) in an animal room with a temperature of 22 2 C, humidity of 60 10% , light dark cycle (12 h; 07:00±19:00 h), and air changes of 15 times/h. T hey were fed a solid stock food (MF, Oriental Yeast Co., Ltd, Tokyo, Japan ) and were allowed free access to water.
All the experiments conformed to the Japanese law concerning anim al care and use, following the G uid e line fo r Anim a l Expe rim e nta tio n recommendations (JALAS 1987 ), and were approved by the Institution's animal care and use committee.
Stud y d e sign a nd b loo d c o lle c tion pro c e d ure s
Forty (20 male and 20 female) 6-week-old speci®c pathogen-free CD rat s (Charles River Japan Inc., Yokoham a, Japan ) were injected intramuscularly with 0.4 ml =kg of turpentine oil (Wak o Pure Chemical Industries, Ltd, Osaka, Japan ).
Blood (0.1 ml) was collected from the subclavian vein of the rats under ether anaesthesia. Sera obtained from the blood were used for the measurement of a2M concentrations and the preparation of a2M fraction as an im munogen.
Pre para tion o f m Ab to a2M
MAb was prepared by means of a standard hybridom a technology with the use of in vivo systemic immunizat ion and polyethylene glyc ol (PEG ) fusion (Cam pbell 1984 ). T he a2M fraction, as an im munogen, was isolated from the rat serum by af® nity chromatography on a column of the rabbit anti-rat a2M IgG fraction coupled with Sepharose 4B (Am ersham Pharmacia Biotech, Uppsala, Sweden). T he a2M fraction was mixed with an equal volume of Freund's complete adjuvant (Difco Laborat ories, Detroit, MI, USA). Female 6-week-old BALB/c mice were immunized intradermally with 0.1 ml of this emulsion. T hree booster im munizations were performed with the a2M fraction without the adjuvant. After three im munizations (initial im munization and two booster immunizati ons), ®nal intra-abdom inal immunizati on with the a2M fraction was carried out 3 days before fusion. Lymphocytes in the spleen were fused with murine myeloma SP2=0 using a 50% (w=v) PEG solution (Sigma Chemical Co., St Louis, MO, USA). Hybridom as were selected in HAT medium (RPMI 1640; Nissui Pharm aceutical Co., Tokyo, Japan ) contai ning 10% heatinactivated foetal bovine serum (Gibco BRL, Grand Island, NY, USA), 2 mM L-glutam ine (Gibco BRL) and 100 U =ml penicillin-streptomycin (Sigma Chemical Co.) contai ning hypoxanthine, aminopterin and thym idine (Sigma Chemical Co.). a2M speci®c-mAbsecreting clones were screened by means of ELISA. Two hybridom as were obtained (A2M K and M ). T he isotype of the mAbs (A2M K and M) was IgG 1. T he mAb secreted by one hybridom a (A2M K) was used for the rat a2M ELISA. T he mAb fraction was isolated from the culture supernat ant on a protein A column (Amersham Pharm acia Biotech).
Po lya c ryla m id e ge l e le c tro ph o re sis a nd We ste rn b lo tting
T he speci®city of the mAb to rat a2M was con®rmed by native PAGE followed by Western blotting using the method by Towbin e t a l. (1979) . T he primary antibody used was the culture supernat ant. A peroxidaseconjugat ed goat anti-m ouse IgG antibody (ICN Biomedicals, Inc., Aurora, OH, USA) was used as the secondary antibody. T he substrat e used was 0.05% 3,3'-diam inobenzidine, tetrahydroc hloride (Wako Pure Chemical Industries, Ltd, Osaka, Japan ). On Western blotting, the mAb (A2M K) gave a single band in the slow mobilit y region with the acute phase serum obtained from a turpentine oil-injected rat.
ELISA fo r a2M
MAb (A2M K), adjusted with 0.05 M sodium bicarbonate buffer (pH 9.6 ) to 1.0 mg=ml, was incubated at 100 ml=well at 37 C for one hour. After blocking with 1% bovine serum albumin in a sodium bicarbonat e buffer (pH 9.6 ), 100 ml=well of serially diluted rat serum with a known a2M concentration (2520 mg of a2M per ml) and the test sera were added. T he plates were incubated at 37 C for 2 h. Peroxidase (Sigma Chemical Co., St Louis, MO, USA) conjugated mAb was prepared by the method of Nakane and Kawaoi (1974 ) , and used at a concentration of 20.0 mg=ml, and the plates were incubated at 37 C for 2 h. T he substrate was 0.05% 2,2-azin o-di-(3-eth ylbenzthiazoline sulphonic acid-6; ABT S) (Zymed Laboratories, South San Francisco, CA, USA). After incubation for 50 min at room temperature, the absorbanc e at 415 nm was measured. T he results were compared with a standard curve obtained using serially diluted specim ens from rats with a known a2M concentration.
T he concentrations of IL-1, IL-2, IL-4, IL-6, IL-8, IL-10 and IFN-g were determ ined using ELISA reagent kit s (Cosmo Bio Co., Ltd, Tokyo, Japan; Wako Pure Chemical Industries, Ltd, Tokyo, Japan ).
Results
Se rum a2M c o nc e ntra tio n fo llo w ing turpe ntine o il inje c tio n T he changes in the a2M concentration in sera from rats injected with turpentine oil are shown in Fig 1. T he mean concentration of a2M gradually increased and peaked 2 days after the turpentine oil injection. T he peak a2M concentration ranged from 2362± 8472 mg=ml (mean 4531 mg=ml), which was 50±290 tim es the pre-inoculation values of 23±61 mg=ml.
C yto k ine c o nc e ntra tio ns fo llo w ing turpe ntine o il inje c tio n
T he concentrations (pre-injection levels) of cytokines in sera from rats are shown in Table 1 . IL-6 and IL-8 increased and peaked 12 h aft er turpentine oil injection (Figs 2 and 3). T he peak IL-6 concentrat ions ranged from 152±1189 pg=ml (mean 554 pg=ml), which were 5±51 tim es the pre-injection levels. T he peak IL-8 concentrations ranged from 2444± 10178 pg=ml (mean 5135 pg=ml), which were 2±38 tim es the pre-injection levels. T he concentrat ions of IL-1, IL-2, IL-4, IL-10 and IFN-g in the sera from the rats injected with turpentine oil did not change.
Discussion
In this study, a speci®c anti-rat a2M antibody (A2M K) was developed for an ELISA to measure rat a2M . T he concentrations of a2M in rat sera pre-injection were similar to results previously reported (Ganrot 1973 , Okubo e t a l. 1981, Inoue e t a l. 2002 ), however, these were much lower than 400 mg=ml, as measured using ELISA techniques in other investigati ons (Ikawa & Shozen 1990 , Kim & Park 1997 . T hese differences may have been due to the use of anti-rat a2M antibodies which included non-speci®c antibodies or to differences in the standardization of these assays.
T he peak responses of a2M in rats at 1±3 days after injection of turpentine oil were The unit for all cytokines is pg=ml. IL = interleukin, IFN = interferon a2-macroglobulin and cytokines in rats similar to those reported previously (Okubo e t a l. 1981). Elevated concentrat ions of IL-6 and IL-8 in rats injected with turpentine oil were demonstrated, and these peaked at approximat ely 12 h, suggesting that IL-6 and IL-8 may be useful as early indicators of in¯ammat ion. 
